Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 06, 2017 ) Browse 219 market data tables and 46 figures spread through 257 pages and in-depth TOC on “Top 10 Bioprocess Technology Market"
http://www.marketsandmarkets.com/Market-Reports/top-10-bioprocess-technology-market-30722776.html
Early buyers will receive 10% customization on this report.
The global top 10 bioprocess technology market is expected to reach USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% from 2016 to 2021.
Rapid growth in pharmaceutical and biotechnology industries, growth in the number of new drug launches, strong trend of R&D in life sciences research, increasing government support for pharmaceutical and biotechnology industries, and rising prevalence of chronic diseases are the key factors driving the growth of this market.
Download PDF Brochure@
http://www.marketsandmarkets.com/pdfdownload.asp?id=30722776
The global top 10 bioprocess technology market is segmented on the basis of type and region. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, flow cytometry, single-use bioprocessing, cell line development, virus filtration, biologics safety testing, pyrogen testing, and tangential flow filtration. In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market.
On the basis of region, the market is segmented into North America, Europe, Asia, and RoW. In 2016, the North American region is expected to account for the largest share of the global top 10 bioprocess technology market. This growth can be attributed to the increased R&D spending by pharmaceutical and biotechnology companies in this region.
Request For Customization Of This Report:
http://www.marketsandmarkets.com/requestCustomization.asp?id=30722776
The prominent players in the top 10 bioprocess technology market include GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441.
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|